4,376
Views
164
CrossRef citations to date
0
Altmetric
Original Research Articles

MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA

, , , , , , , , , & show all
Article: 29828 | Received 22 Sep 2015, Accepted 21 Jan 2016, Published online: 24 Feb 2016

References

  • Yeo RW, Lai RC, Zhang B, Tan SS, Yin Y, Teh BJ, etal. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev. 2013; 65: 336–41.
  • Timmers L, Lim S-K, Arslan F, Armstrong JS, Hoefler IE, Doevendans PA, etal. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 2008; 1: 129–37.
  • Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, etal. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010; 4: 214–22.
  • Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res. 2010; 38: 215–24.
  • Tan SS, Yin Y, Lee T, Lai RC, Yeo RW, Zhang B. Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane. J Extracell Vesicles. 2013; 2: 22614, doi: http://dx.doi.org/10.3402/jev.v2i0.22614.
  • Lotvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, etal. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the international society for extracellular vesicles. J Extracell Vesicles. 2014; 3: 26913,. doi: http://dx.doi.org/10.3402/jev.v3.22913.
  • Chen TS, Arslan F, Yin Y, Tan SS, Lai RC, Choo AB, etal. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med. 2011; 9: 47.
  • Lai RC, Arslan F, Tan SS, Tan B, Choo A, Lee MM, etal. Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. J Mol Cell Cardiol. 2010; 48: 1215–24.
  • Sze SK, de Kleijn DP, Lai RC, Tan EKW, Zhao H, Yeo KS, etal. Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics. 2007; 6: 1680–9.
  • Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, de Kleijn DP, etal. Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int J Proteomics. 2012; 2012: 971907.
  • Caswell PT, Vadrevu S, Norman JC. Integrins: masters and slaves of endocytic transport. Nat Rev Mol Cell Biol. 2009; 10: 843–53. doi: http://dx.doi.org/10.1038/nrm2799.
  • Pitulescu ME, Adams RH. Eph/ephrin molecules—a hub for signaling and endocytosis. Gene Dev. 2010; 24: 2480–92.
  • Kopera IA, Bilinska B, Cheng CY, Mruk DD. Sertoli-germ cell junctions in the testis: a review of recent data. Philos Trans R Soc Lond B Biol Sci. 2010; 365: 1593–605.
  • Yan HH, Mruk DD, Wong EW, Lee WM, Cheng CY. An autocrine axis in the testis that coordinates spermiation and blood-testis barrier restructuring during spermatogenesis. Proc Natl Acad Sci USA. 2008; 105: 8950–5.
  • Delva E, Kowalczyk AP. Regulation of cadherin trafficking. Traffic. 2009; 10: 259–67.
  • Welch MD, Mullins RD. Cellular control of actin nucleation. Annu Rev Cell Dev Biol. 2002; 18: 247–88.
  • Bashaw GJ, Klein R. Signaling from axon guidance receptors. Cold Spring Harb Perspect Biol. 2010; 2: a001941.
  • Sorkin A, von Zastrow M. Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol. 2009; 10: 609–22.
  • Schiefermeier N, Teis D, Huber LA. Endosomal signaling and cell migration. Curr Opin Cell Biol. 2011; 23: 615–20.
  • Buszczak M, Signer Robert AJ, Morrison Sean J. Cellular differences in protein synthesis regulate tissue homeostasis. Cell. 2014; 159: 242–51.
  • Bonifacino JS, Rojas R. Retrograde transport from endosomes to the trans-Golgi network. Nat Rev Mol Cell Biol. 2006; 7: 568–79.
  • Lodish H BA, Zipursky SL, etal. Section 17.3, Overview of the secretory pathway. Molecular cell biology. 4th ed. 2000; New York: W.H. Freeman.
  • Alberts B JA, Lewis J, etal. Transport into the cell from the plasma membrane: endocytosis. Molecular biology of the cell. 4th ed. 2002; New York: Garland Science.
  • Choi D-S, Kim D-K, Kim Y-K, Gho YS. Proteomics of extracellular vesicles: exosomes and ectosomes. Mass Spectrom Rev. 2015; 34: 474–90.
  • Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, etal. Human keratinocytes that express hTERT and also Bypass a p16(INK4a)-Enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol. 2000; 20: 1436–47.
  • Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regenerative medicine. 2011; 6(4): 481–92.
  • Maffey KG, Keil LB, DeBari VA. The Influence of lipid composition and divalent cations on annexin v binding to phospholipid mixtures. Ann Clin Lab Sci. 2001; 31: 85–90.
  • Leventis PA, Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys. 2010; 39: 407–27.
  • Lizarbe M, Barrasa J, Olmo N, Gavilanes F, Turnay J. Annexin-phospholipid interactions. Functional implications. Int J Mol Sci. 2013; 14: 2652.
  • Meers P, Mealy T. Calcium-dependent annexin V binding to phospholipids: stoichiometry, specificity, and the role of negative charge. Biochemistry. 1993; 32: 11711–21.
  • Sopkova J, Renouard M, Lewit-Bentley A. The crystal structure of a new high-calcium form of annexin V. J Mol Biol. 1993; 234: 816–25.
  • Merritt EA, Sarfaty S, van den Akker F, L'Hoir C, Martial JA, Hol WG. Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide. Protein Sci. 1994; 3: 166–75.
  • Ling H, Boodhoo A, Hazes B, Cummings MD, Armstrong GD, Brunton JL, etal. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry. 1998; 37: 1777–88.